Tenax Therapeutics, Inc. · NASDAQ:TENX
Staab Thomas R II received 10,000 Tenax Therapeutics, Inc. shares as an award (Form 4)
Traded May 11, 2026 · Filed May 13, 2026
On May 11, 2026, Staab Thomas R II (Chief Financial Officer) received 10,000 Tenax Therapeutics, Inc. shares as an award, leaving 10,000 shares. Filed May 13, 2026 (Form 4).
- Awarded
- 10,000 shares
- Holding after
- 10,000 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 11, 2026 | Common Stock | Award | 10,000 | 10,000 | Direct |
Source
Related
- Tenax Therapeutics, Inc.
- Staab Thomas R II
- Tenax Therapeutics, Inc. shareholders
- Form 4 · Staab Thomas R II · Sep 15, 2026
- Form 4 · ADAR1 Capital Management, LLC · Oct 21, 2026
- Schedule 13G/A · Millennium Management LLC · Oct 15, 2026
- Schedule 13G/A · Sphera Funds Management LTD. · Oct 13, 2026
- Schedule 13G/A · Dellora Investments LP · Oct 9, 2026
- Form 4 · Doogan Declan · Sep 17, 2026